Interestingly, the MEK/ERK cascade has been demonstrated to control cell motility in HCC cell models, through a mechanism involving urokinase receptor (uPAR)-mediated phosphorylation/activation of p70S6K (65). This evidence concerns the gene MAP2K7 and hepatocellular carcinoma.